Qianliguang (Senecio scandens) Safety Dilemma: Dose Is the Key?

Abstract

Qianliguang (Senecio scandens) is a common Chinese medicinal herb. Qianliguang-containing herbal proprietary products are registered as over-the-counter remedies in China and exported to Western countries. The safety of using Qianliguang and its products has raised general concerns because of a potential risk of the presence of hepatotoxic pyrrolizidine alkaloids (PAs). A systematic toxicological study is thus required to verify this public concern. In the present article, we report, for the first time, that S. scandens contains nine hepatotoxic PAs with a content of 6.95–7.19 µg/g. At a dose equivalent to the daily intake recommended by the Pharmacopoeia of China, the total content of toxic PAs in Qianliguang was determined to be 3.48 µg/kg/day, which is far below the lowest dose to cause hepatotoxicity (15 µg/kg/day) suggested by the International Program on Chemical Safety. No significant hepatotoxic effects were observed in rats fed with the extract at this human-equivalent dose for 14 consecutive days. However, a single overdose of the herbal water extract (6 g/kg), which was about 8-fold higher than the recommended dose, produced typical PA-induced hepatotoxicity in rats. Therefore, appropriate dosage guidelines should be implemented for the herbal industry, for export/import retailers, and for herbal medicine practitioners to ensure the safe and beneficial use of these herbal medicines.

Key words

pyrrolizidine alkaloid - hepatic veno‐occlusive disease - Senecio scandens - Qianliguang - Asteraceae

References

• 1 Barnes J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: efficacy and safety.  Br J Clin Pharmacol. 2003;  55 331-340
• 2 Barnes J. Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I: regulation and quality.  Br J Clin Pharmacol. 2003;  55 226-233
• 3 Fu P P, Xia Q, Lin G, Chou M W. Pyrrolizidine alkaloids – genotoxicity, metabolism enzymes, metabolic action, and mechanisms.  Drug Metab Rev. 2004;  36 1-55
• 4 Xia Q S, Chou M W, Lin G, Fu P P. Metabolic formation of DHP-derived DHA adducts from a representative otonecine-type pyrrolizidine alkaloid clivorine and the extract of ligularia hodgsonnii hook.  Chem Res Toxicol. 2004;  1 702-708
• 5 Fu P P, Xia Q S, Chou M W, Lin G. Detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids in Chinese herbal plants and herbal dietary supplements.  J Food Drug Anal. 2007;  15 400-415
• 6 Dharmananda S. Safety issue affecting herbs: pyrrolizidine alkaloids. Monograph on the Internet. Available at http://www.itmonline.org/arts/pas.htm . 
• 7 The Committee of Pharmacopoeia of the People's Republic of China .Pharmacopoeia of the People's Republic of China. Beijing; Chemistry Industry Press 2005: 337-338 appendix: 22
• 8 Liang A H, Ye Z G. General situation of the toxicity researches on Senecio.  China J Chin Mater Med. 2006;  31 93-97
• 9 Medicines and Healthcare Products Regulatory Agency .MLX 296: proposals to prohibit the sale, supply or importation of unlicensed herbal medicinal products for internal use which contain Senecio species. Monograph on the Internet. Available at http://www.mhra.gov.uk/home/idcplg?IdcService=SS_GET_PAGE &useSecondary=true&ssDocName=CON1004416&ssTargetNodeId=373. Accessed January 29, 2004
• 10 Medicines and Healthcare products Regulatory Agency .Public consultation: Proposals to prohibit the sale, supply or importation of unlicensed medicinal products for internal use which contain Senecio species and proposals to amend three existing orders. Monograph on the Internet. Available at http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&dDocName=CON2030749&RevisionSelectionMethod=LatestReleased. Accessed March 27, 2007
• 11 Harmann T, Dierich B. Chemical diversity and variation of pyrrolizidine alkaloids of the senecionine type: biological need or coincidence.  Planta. 1998;  206 443-451
• 12 Li S L, Lin G, Fu P P, Chan C L, Li M, Jiang Z H, Zhao Z Z. Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used Chinese medicinal herb, Herba Senecionis Scandentis (Qianliguang).  Rapid Commun Mass Spectrom. 2008;  22 591-602
• 13 Lin G, Nnane I P, Cheng T Y. The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats.  Toxicon. 1999;  37 1259-1270
• 14 Lin G, Cui Y Y, Hawes E M. Characterization of rat liver microsomal metabolites of clivorine, a hepatotoxic otonecine-type pyrrolizidine alkaloid.  Drug Metab Dispos. 2000;  28 1475-1483
• 15 Lin G, Tang J, Liu X Q, Jiang Y, Zheng J. Deacetylclivorine: a gender-selective metabolite of clivorine formed in female SD rat liver microsomes.  Drug Metab Dispos. 2007;  35 607-613
• 16 Lin G, Zhou K Y, Zhao X G, Wang Z T, But P P. Determination of hepatotoxic pyrrolizidine alkaloids by on-line high performance liquid chromatography mass spectrometry with an electrospray interface.  Rapid Commun Mass Spectrom. 1998;  12 1445-1456
• 17 Magnabosco E M, Rivera M L, Prolla I R, de Verney Y M, de Mello E S. Hepatic veno-occlusive disease: report of a case.  J Pediatr (Rio J). 1997;  73 115-118
• 18 Stillman A S, Huxtable R, Consroe P, Kohnen P, Smith S. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona.  Gastroenterology. 1977;  73 349-352
• 19 Tomioka M, Calvo F, Siguas A, Sanchez L, Nava E, Garcia U, Valdivia M, Reategui E. Hepatic veno-occlusive disease associated with ingestion of Senecio tephrosioides.  Rev Gastroenterol Peru. 1995;  15 299-302
• 20 Vilar J H, Garcia M, Cabrera P. Veno-occlusive liver disease induced by Senecio vulgaris toxicity.  Gastroenterol Hepatol. 2000;  23 285-286
• 21 Batra V, Rajagopalan T R. Alkaloidal constituents of Senecio scandens.  Curr Sci. 1977;  46 141
• 22 Xu X B, Lin H Y, Feng Y S, Chen J J. Preliminary phytochemical test of Senecio scandens Buch.-Ham. and examination on chemical composition of its antimicrobial part.  J Tradit Chin Vet Med. 2006;  25 10-13
• 23 Yu L, Xu Y, Feng H, Li S F. Separation and determination of toxic pyrrolizidine alkaloids in traditional Chinese medicines by micellar electrokinetic chromatography with organic modifier.  Electrophoresis. 2005;  26 3397-3404
• 24 Tian X Y, Wang Y H, Yang Q Y, Liu X, Fang W S, Yu S S. Jacaranone glycosides from Senecio scandens.  J Asian Nat Prod Res. 2006;  8 125-132
• 25 Ulrich R G. Idiosyncratic toxicity: a convergence of risk factors.  Anu Rev Med. 2007;  58 17-34
• 26 Lammert G, Einarsson S, Saha C, Niklasson A, Bjornsson E, Chalasani N. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals.  Hepatology. 2008;  47 2003-2009
• 27 International Program on Chemical Safety .Environmental health criteria 80: pyrrolizidine alkaloids. Monograph on the Internet. Available at http://www.inchem.org/documents/ehc/ehc/ehc080.htm
• 28 International Program on Chemical Safety .Health and safety guide no. 26: pyrrolizidine alkaloids health and safety guide. Monograph on the Internet. Available at http://www.inchem.org/documents/hsg/hsg/hsg026.htm
• 29 Zhao X Z, Wang Z T, Lin G, Cui Y Y, Zhang M, Xu L S, Xu G J, Damani L A. Hepatotoxic pyrrolizidine alkaloids and traditional Chinese medicines.  Chin Tradit Herb Drugs. 1998;  29 343-346
• 30 Heberer T, Lahrssen-Wiederholt M, Schafft H, Abraham K, Pzyrembel H, Henning K J, Schauzu M, Braeunig J, Goetz M, Niemann L, Gundert-Remy U, Luch A, Appel B, Banasiak U, Boel G F, Lamper A, Wittkowski R, Hensel A. Zero tolerances in food and animal feed – are there any scientific alternatives? A European point of view on an international controversy.  Toxicol Lett. 2007;  175 118-135